Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

Lowie Vanfleteren; Leonardo M. Fabbri; Alberto Papi; Stefano Petruzzelli; Bartolome Celli

doi:10.2147/COPD.S185975

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

Lowie Vanfleteren, Leonardo M. Fabbri, Alberto Papi, Stefano Petruzzelli, Bartolome Celli

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	3971-3981
Number of pages	11
Journal	International journal of chronic obstructive pulmonary disease
Volume	13
DOIs	https://doi.org/10.2147/COPD.S185975
Publication status	Published - 1 Jan 2018

Keywords

muscarinic antagonists
adrenergic beta(2) receptor agonists
glucocorticoids
pulmonary disease
chronic obstructive
review
exacerbations
safety
OBSTRUCTIVE PULMONARY-DISEASE
DOUBLE-BLIND
INHALED CORTICOSTEROIDS
FLUTICASONE PROPIONATE/SALMETEROL
PARALLEL-GROUP
BRONCHODILATOR THERAPY
CARDIOVASCULAR EVENTS
AIRWAY INFLAMMATION
BETA-AGONISTS
TIOTROPIUM

Access to Document

10.2147/COPD.S185975Licence: CC BY-NC

Cite this

Vanfleteren, L., Fabbri, L. M., Papi, A., Petruzzelli, S., & Celli, B. (2018). Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal. International journal of chronic obstructive pulmonary disease, 13, 3971-3981. https://doi.org/10.2147/COPD.S185975

@article{5512ccd104da4872bf861e602f9ef543,

title = "Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal",

keywords = "muscarinic antagonists, adrenergic beta(2) receptor agonists, glucocorticoids, pulmonary disease, chronic obstructive, review, exacerbations, safety, OBSTRUCTIVE PULMONARY-DISEASE, DOUBLE-BLIND, INHALED CORTICOSTEROIDS, FLUTICASONE PROPIONATE/SALMETEROL, PARALLEL-GROUP, BRONCHODILATOR THERAPY, CARDIOVASCULAR EVENTS, AIRWAY INFLAMMATION, BETA-AGONISTS, TIOTROPIUM",

author = "Lowie Vanfleteren and Fabbri, {Leonardo M.} and Alberto Papi and Stefano Petruzzelli and Bartolome Celli",

year = "2018",

month = jan,

day = "1",

doi = "10.2147/COPD.S185975",

language = "English",

volume = "13",

pages = "3971--3981",

journal = "International journal of chronic obstructive pulmonary disease",

issn = "1178-2005",

publisher = "Dove Medical Press Ltd",

}

TY - JOUR

T1 - Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

AU - Vanfleteren, Lowie

AU - Fabbri, Leonardo M.

AU - Papi, Alberto

AU - Petruzzelli, Stefano

AU - Celli, Bartolome

PY - 2018/1/1

Y1 - 2018/1/1

KW - muscarinic antagonists

KW - adrenergic beta(2) receptor agonists

KW - glucocorticoids

KW - pulmonary disease

KW - chronic obstructive

KW - review

KW - exacerbations

KW - safety

KW - OBSTRUCTIVE PULMONARY-DISEASE

KW - DOUBLE-BLIND

KW - INHALED CORTICOSTEROIDS

KW - FLUTICASONE PROPIONATE/SALMETEROL

KW - PARALLEL-GROUP

KW - BRONCHODILATOR THERAPY

KW - CARDIOVASCULAR EVENTS

KW - AIRWAY INFLAMMATION

KW - BETA-AGONISTS

KW - TIOTROPIUM

U2 - 10.2147/COPD.S185975

DO - 10.2147/COPD.S185975

M3 - Review article

VL - 13

SP - 3971

EP - 3981

JO - International journal of chronic obstructive pulmonary disease

JF - International journal of chronic obstructive pulmonary disease

SN - 1178-2005

ER -